RAMMURTI KAMBLE to United States
This is a "connection" page, showing publications RAMMURTI KAMBLE has written about United States.
Connection Strength
0.161
-
Participation of African American Persons in Clinical Trials Supporting U.S. Food and Drug Administration Approval of Cancer Drugs. Ann Intern Med. 2020 08 18; 173(4):320-322.
Score: 0.059
-
Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study. Leuk Lymphoma. 2021 12; 62(13):3256-3263.
Score: 0.016
-
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Blood. 2021 01 28; 137(4):556-568.
Score: 0.015
-
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. Cancer. 2021 02 15; 127(4):609-618.
Score: 0.015
-
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States. Cancer. 2021 01 01; 127(1):82-92.
Score: 0.015
-
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica. 2017 11; 102(11):1823-1832.
Score: 0.012
-
Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transplant. 2016 Mar; 22(3):520-7.
Score: 0.011
-
New cancers after autotransplantations for multiple myeloma. Biol Blood Marrow Transplant. 2015 Apr; 21(4):738-45.
Score: 0.010
-
Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013 Aug; 48(8):1091-7.
Score: 0.009